Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of incretin effect on immunological phenotype in healthy subjects and type 1 diabetes
2011-006300-12Phase 4Terminated
- Sponsor
- Medical University of Graz, Department of Endocrinology and Metabolism
- Start
- Jan 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of liraglutide and saxagliptin in diabetes mellitus type 1 (T1D), sponsored by Medical University of Graz, Department of Endocrinology and Metabolism. Started Jan 2012; status: terminated.
02
Drugs
liraglutidesaxagliptin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2011-006300-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006300-12.